X0206 3/A 2019-01-01 2019-01-10 0 0001668243 UroGen Pharma Ltd. URGN 0001339358 Cohen Fred E C/O UROGEN PHARMA LTD. 9 HA?TA?ASIYA STREET RA?ANANA L3 4365007 ISRAEL 1 0 0 0 Stock Option (right to buy) 16.99 2027-05-15 Ordinary Shares 40000 D Stock Option (right to buy) 59.23 2028-06-04 Ordinary Shares 10000 D 6.25% of the shares underlying the stock option vested on each of August 15, 2017, November 15, 2017 and February 15, 2018; 31.25% of the shares vested May 15, 2018 and the remaining shares will vest in equal quarterly installment commencing 3 months after May 15, 2018. The information in column 3 and column 4 were inadvertently transposed on the initial Form 3 filing. 25% of the shares underlying the stock option vested on each of September 4, 2018 and December 4, 2018 and the remaining shares will in two equal installments on March 4, 2019 and June 4, 2019. /s/ Peter Pfreundschuh, Attorney-in-Fact 2019-01-15